{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995493544192.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3109/0886022x.2011.647293"}},{"identifier":{"@type":"URI","@value":"http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2011.647293"}}],"dc:title":[{"@value":"The Role of Nafamostat Mesylate in Continuous Renal Replacement Therapy among Patients at High Risk of Bleeding"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995493544192","@type":"Researcher","foaf:name":[{"@value":"Na Na Baek"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544197","@type":"Researcher","foaf:name":[{"@value":"Hye Ryoun Jang"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544196","@type":"Researcher","foaf:name":[{"@value":"Wooseong Huh"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544195","@type":"Researcher","foaf:name":[{"@value":"Yoon-Goo Kim"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544193","@type":"Researcher","foaf:name":[{"@value":"Dae Joong Kim"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544320","@type":"Researcher","foaf:name":[{"@value":"Ha Young Oh"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995493544194","@type":"Researcher","foaf:name":[{"@value":"Jung Eun Lee"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0886022X"},{"@type":"EISSN","@value":"15256049"}],"prism:publicationName":[{"@value":"Renal Failure"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2012-01-17","prism:volume":"34","prism:number":"3","prism:startingPage":"279","prism:endingPage":"285"},"reviewed":"false","url":[{"@id":"http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2011.647293"}],"createdAt":"2012-01-17","modifiedAt":"2021-12-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050300324657620992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Amniotic fluid embolism rescued using venoarterial extracorporeal membrane oxygenation without initial anticoagulation: A case report and literature review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657465870976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704799231488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390864977280519168","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Usage of nafamostat mesylate during continuous renal replacement therapy and filter life: a scoping review"},{"@language":"ja","@value":"持続的腎代替療法中のナファモスタットメシル酸塩の使用方法とフィルターライフ：スコーピングレビュー"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3109/0886022x.2011.647293"},{"@type":"CROSSREF","@value":"10.3918/jsicm.31_582_references_DOI_SqKY9T0YnM6UVbSBTDIb27YwvWk"},{"@type":"CROSSREF","@value":"10.1097/md.0000000000038176_references_DOI_SqKY9T0YnM6UVbSBTDIb27YwvWk"},{"@type":"CROSSREF","@value":"10.1186/s12882-023-03060-1_references_DOI_SqKY9T0YnM6UVbSBTDIb27YwvWk"},{"@type":"CROSSREF","@value":"10.1016/j.transci.2017.08.015_references_DOI_SqKY9T0YnM6UVbSBTDIb27YwvWk"}]}